drugset / Trial / NCT01177163
A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacodynamic effects and pharmacokinetic characteristics of JNJ-28431754 after multiple dosing in patients with Type 2 Diabetes Mellitus who are on a stable dose of insulin.
Timeline
- Start
- 2008-05
- Primary completion
- —
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ 28431754 300 mg/placebo | Unknown | 100 mg | Oral |
| Subject | JNJ 28431754 300 mg/placebo | Unknown | 300 mg | Oral |